Home › Compare › APTCF vs NOBL

APTCF vs NOBL: Dividend Comparison 2026

APTCF yields 1000000.00% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APTCF wins by $4.7683925249533696e+36M in total portfolio value
10 years
APTCF
APTCF
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full APTCF calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — APTCF vs NOBL

📍 APTCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPTCFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APTCF + NOBL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
APTCF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APTCF
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, APTCF beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APTCF + NOBL for your $10,000?

APTCF: 50%NOBL: 50%
100% NOBL50/50100% APTCF
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APTCF buys
0
NOBL buys
0
No recent congressional trades found for APTCF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPTCFNOBL
Forward yield1000000.00% ✓2.17%
Annual dividend / share$2.00$2.27 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.7683925249533696e+36M$22.9K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$249.78
Total dividends collected$4.7683311610149396e+36M ✓$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: APTCF vs NOBL ($10,000, DRIP)

YearAPTCF PortfolioAPTCF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,917$217.08+$100.00M → APTCF
2$934,786,450,701$934,679,439,252.34$11,903$221.48+$934786.44M → APTCF
3$8,165,787,108,578,292$8,164,786,887,076,042.00$12,962$225.68+$8165787108.57M → APTCF
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$14,099$229.68+$66665884190957.63M → APTCF
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$15,319$233.49+$508662171058048128.00M → APTCF
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$16,628$237.10+$3.62723524842849e+21M → APTCF
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$18,033$240.53+$2.417368115915061e+25M → APTCF
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$19,539$243.78+$1.5056740286145463e+29M → APTCF
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$21,154$246.86+$8.764771002818475e+32M → APTCF
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$22,884$249.78+$4.7683925249533696e+36M → APTCF

APTCF vs NOBL: Complete Analysis 2026

APTCF — Stock

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.

Full APTCF Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this APTCF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APTCF vs SCHDAPTCF vs JEPIAPTCF vs OAPTCF vs KOAPTCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.